Westland Milk Products breaks ground on lactoferrin plant in New Zealand
Lactoferrin is a scarce resource for the dairy industry
29 May 2023
2 minute read
By: Yili subsidiary Westland Milk Products held a groundbreaking ceremony for the construction of its NZD 70 million (USD 42.58 million) lactoferrin plant at Hokitika, New Zealand last week.
The ceremony was attended by New Zealand's Trade, Export and Agriculture Minister and MP for West-Coast Tasman, Damien O'Connor; Director-General of the Ministry for Primary Industries, Ray Smith; Chinese Ambassador to New Zealand, Wang Xiao Long; and Chinese Consul-General in Christchurch, He Ying.
Westland CEO Richard Wyeth welcomed guests and provided them with an overview of the background of the lactoferrin project. Yili Westland's Resident Director, Zhiqiang Li, spoke about the global market advantage that both Westland and Yili would gain from Yili's investment in the new lactoferrin plant.
The investment will enable Yili to rank amongst the top three leading global companies in the lactoferrin category, with a market share of approximately 10 per cent.
"Today's launch of the lactoferrin program will secure Westland as one of the world's leading producers of highly prized bioactive ingredients," Li told invited guests. "The investment also signals Yili's commitment to take the global lead in the high-value bioactive dairy ingredients sector."
"We were one of the first to market with this highly specialised protein ingredient, and over the past 20 years have established a reputation as a manufacturer of a product of exceptional quality," Wyeth said. "Our bioactive ingredients innovation pipeline is well advanced, and we're excited to be a step closer to bringing these concepts to commercialisation."
Lactoferrin, a multifunctional natural protein, offers immune benefits as well as antibacterial and antioxidant functions and is now widely used in food, pharmaceutical products and in other industries. As a consumer-oriented enterprise, Yili has anticipated consumers' needs for products such as lactoferrin and is determined to bring more nutritious and healthy products to global markets. The company has invested considerable resources in R&D to tackle lactoferrin extraction challenges.
Over the years, Yili has successfully developed its own directional lactoferrin extraction and protection technology, which can significantly enhance the quality of protein ingredients and increase extraction efficiency.
According to analysts, lactoferrin is a crucial and scarce resource for the dairy industry. This project is therefore a significant step in Yili's efforts at overcoming core technological barriers, strengthening its global influence, and developing its long-term strategic layout.
